Evidence map›Paper›PMID 37758649›Full record

ArticleJournal of the International AIDS Society2023

Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.

Lindsey de Vos, Emily Krogstad Mudzingwa, Lauren Fynn, Millicent Atujuna, Matinatsa Mugore, Monica Gandhi, Connie Celum, Sybil Hosek, Linda-Gail Bekker, Joseph Daniels and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Lindsey de VosResearch Unit, Foundation for Professional Development, East London, South Africa.ORCID 0000-0001-5804-7651
Emily Krogstad MudzingwaThe Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Lauren FynnThe Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Millicent AtujunaThe Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.ORCID 0000-0003-1287-2634
Matinatsa MugoreMailman School of Public Health, Columbia University, New York, New York, USA.
Monica GandhiDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0002-7025-1994
Connie CelumDepartments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-8813-3419
Sybil HosekDivision of Infectious Diseases, Stroger Hospital of Cook County, Chicago, Illinois, USA.
Linda-Gail BekkerThe Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-0755-4386
Joseph DanielsEdson College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona, USA.ORCID 0000-0002-0985-5916
Andrew Medina-MarinoThe Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-0095-4141
Desmond Tutu HIV Foundation · ZAZero to Three · USColumbia University · USJohn H. Stroger, Jr. Hospital of Cook County · USUniversity of California, San Francisco · USUniversity of Washington · US

Funding

Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING-PUMA)R01AI143340 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 2018 to 2026
$5.6M
The Community PrEP StudyR01MH114648 · NIMH · FOUNDATION FOR PROFESSIONAL DEVELOPMENT · PI BEKKER, LINDA-GAIL GAIL, MEDINA-MARINO, ANDREW · 2017 to 2021
$2.4M
NIAID NIH HHS R01 AI143340NIMH NIH HHS R01 MH114648
6 · The paper itself

Abstract

introductionAdolescent girls and young women (AGYW) face barriers that jeopardize their prevention-effective use of daily oral pre-exposure prophylaxis (PrEP). We sought to understand factors that influence AGYW's prolonged breaks in PrEP use, and their decisions to re-initiate or discontinue using PrEP in the context of a community-based adherence support intervention.

methodsIn-depth interviews (IDIs) were conducted between December 2019 and April 2021 with purposively selected AGYW (aged 16-25) enrolled in the Community PrEP Study (CPS) in Buffalo City Metro Health District, Eastern Cape Province, South Africa. AGYW were offered monthly PrEP for 24 months at two community-based study sites. Interview guides were informed by the Information-Motivation-Behavioural Skills Model, and data were analysed using illustrative code reports and a case analysis.

resultsA total of 603 participants were enrolled and initiated on PrEP in the parent study. Fifty-three IDIs were conducted with 50 CPS participants. Findings revealed that external factors (e.g. local movement, school holidays and medication side-effects) and social conflicts (e.g. discretion and partner mistrust) directly influenced breaks in PrEP usage. A decrease in one's self-perception of HIV risk prolonged the duration of these "PrEP breaks." Once PrEP refill visits were missed, some AGYW delayed returning for refills out of fear of being scolded by study staff. The differences between those participants who eventually re-initiated PrEP and those who disengaged from PrEP use can be attributed to social support and encouragement, level of familiarity with PrEP, risk perceptions, self-initiated discussions with staff and diminishing side effects.

conclusionsDespite implementing a community-based PrEP delivery platform and behavioural intervention that included support for daily oral PrEP adherence and disclosure, participants struggled with consistent daily oral PrEP use. Unpredictable life events, including local movement and schooling schedules, in addition to being judged for their perceived behaviours, pose a challenge for consistent pill pick-up for AGYW and habit formation. Long-acting injectable PrEP may mitigate a number of these external barriers. Interventions that integrate long-term planning skills, how to navigate existing social judgements and how to access sources of social support may further improve habit formation for PrEP use, regardless of its formulation.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdolescentFemaleHumansQualitative ResearchSouth AfricaAnti-HIV Agentsadherenceadolescent girls and young womendiscontinuationoral pre-exposure prophylaxisPrEPSouth Africa

Identifiers

PMID37758649
PMCPMC10533377
OpenAlexW4387078975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.